Exton gene and cell therapy company to be sold in $63.3M deal
Castle Creek Pharmaceuticals Holdings has reached an agreement to acquire Chester County cell and gene therapy company Fibrocell Science Inc. in a deal valued at $63.3 million.
According to documents filed with the Securities and Exchange Commission, Castle Creek will pay Fibrocell stockholders $3 for each held and assume Fibrocell's debt. The purchase price represents a 63% premium compared to the company’s average trading levels during the last month.
The deal, whic h still requires shareholder…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news